Abiogen Pharma Competitors and Similar CompaniesClear all
Abiogen Pharma's competitors and similar companies include Pharming Group, Alexion Pharmaceuticals, Crinetics Pharmaceuticals and Macopharma.
 Abiogen Pharma Abiogen Pharma is a specialist pharmaceutical company that focuses on bone metabolism and rare diseases. |  Pharming Group Pharming Group is a biopharmaceutical company developing protein replacement therapies and precision medicines for the treatment of rare diseases. |  Alexion Pharmaceuticals Alexion (also known as Alexion, AstraZeneca Rare Disease) is a biopharmaceutical company engaged in therapies for rare diseases. |  Crinetics Pharmaceuticals Crinetics Pharmaceuticals is a clinical-stage pharmaceutical company that develops and commercializes therapeutics for rare endocrine diseases and endocrine-related tumors. | ||
Founding Date | Founding Date 1997 | Founding Date 1988 | Founding Date 1992 | Founding Date 2008 | Founding Date 1977 |
Type | Type Subsidiary | Type Public | Type Public | Type Public | Type Private |
Tags | |||||
Locations | Locations Pisa, IT HQ | Locations Leiden, NL HQ Leiden, NL | Locations Boston, US HQ Frenchs Forest, AU Wien, AT Elsene, BE São Paulo, BR Vaughan, CA Shanghai, CN see more | Locations San Diego, US HQ | Locations Tourcoing, FR HQ Mouvaux, FR |
Employees | Employees 351 | Employees 404 | Employees 10,6006% increase | Employees 43751% increase | Employees 901 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 590.3 m | Valuation ($) 40.3 b | Valuation ($) 5.1 b | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $376.1m (FY, 2025) | Revenue (est.) $6.1b (FY, 2020) | Revenue (est.) $7.7m (FY, 2025) | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods $41.6m (FY, 2025) | Cost of goods $553.5m (FY, 2020) | Cost of goods $1.1m (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit $341m (FY, 2025) | Gross profit $5.5b (FY, 2020) | Gross profit $6.6m (FY, 2025) | Gross profit N/A |
Net income | Net income N/A | Net income $2.5m (FY, 2025) | Net income $603.4m (FY, 2020) | Net income ($465.3m) (FY, 2025) | Net income N/A |
For sources of this data, please see the company profile
View Company Profiles
Pharming Group
HQ
Leiden, NL
Employees
404
Pharming Group is a biopharmaceutical company developing protein replacement therapies and precision medicines for the treatment of rare diseases.
View companyAlexion Pharmaceuticals
HQ
Boston, US
Employees
10,600↑ 6% increase
Alexion (also known as Alexion, AstraZeneca Rare Disease) is a biopharmaceutical company engaged in therapies for rare diseases.
View companyCrinetics Pharmaceuticals
HQ
San Diego, US
Employees
437
Crinetics Pharmaceuticals is a clinical-stage pharmaceutical company that develops and commercializes therapeutics for rare endocrine diseases and endocrine-related tumors.
View company
Macopharma
HQ
Tourcoing, FR
Employees
901
Macopharma is a provider of blood transfusion and bio-sourced therapies.
View company